XML 30 R3.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 74,603 $ 55,499
Marketable securities, current 173,934 189,405
Accounts receivable 2,401 3,102
Prepaid expenses and other current assets 7,172 9,761
Total current assets 258,110 257,767
Marketable securities, non-current 48,563 22,359
Property and equipment, net 4,744 5,842
Right-of-use asset 40,532 57,536
Restricted cash 3,443 3,443
Other assets 3,683 2,655
Total assets 359,075 349,602
Current liabilities:    
Accounts payable 858 1,328
Accrued expenses and other current liabilities 13,314 19,363
Deferred revenue, current 12,493 18,712
Operating lease liability, current 6,367 5,774
Total current liabilities 33,032 45,177
Deferred revenue, net of current 15,841 28,457
Operating lease liability, net of current 53,615 59,982
Total liabilities 102,488 133,616
Commitments and contingencies (See Note 6 and Note 9)
Stockholders’ equity:    
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of December 31, 2025 and 2024, respectively 0 0
Common stock, par value of $0.0001 per share; 300,000,000 and 150,000,000 shares authorized as of December 31, 2025 and December 31, 2024, and 96,914,418 and 70,625,899 shares issued and outstanding as of December 31, 2025 and 2024, respectively 9 7
Additional paid-in capital 995,221 849,625
Accumulated other comprehensive income 50 53
Accumulated deficit (738,693) (633,699)
Total stockholders’ equity 256,587 215,986
Total liabilities and stockholders’ equity $ 359,075 $ 349,602